MedWatch

Novo Holdings prepares for major US offensive

Danish investment company Novo Holdings is planning to make more major investments in the US. The board has not made an official decision yet, but the plans will likely entail adding more employees to the company’s current office in Boston, says CEO Kasim Kutay.

Foto: Kenneth Koustrup Lysbjerg/Finans

Denmark’s biggest life science investment company, Novo Holdings, has great plans for its activities on the US market, where it aims to make more large investments in the future. A likely expansion of the company's work force in the country should help it to realize those ambitions, says CEO Kasim Kutay in an interview with MedWatch.

”There is a high likelihood that we will have a presence in the US in Principal Investments some time in the medium term, although no formal decision has yet been taken,” says the chief executive.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier